Logo image of STRS

STRATUS PROPERTIES INC (STRS) Stock Fundamental Analysis

USA - NASDAQ:STRS - US8631672016 - Common Stock

19.3 USD
-0.34 (-1.73%)
Last: 10/21/2025, 8:00:00 PM
Fundamental Rating

1

STRS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of STRS have multiple concerns. STRS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

STRS had negative earnings in the past year.
In the past year STRS has reported a negative cash flow from operations.
In multiple years STRS reported negative net income over the last 5 years.
In the past 5 years STRS always reported negative operating cash flow.
STRS Yearly Net Income VS EBIT VS OCF VS FCFSTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.61%, STRS is in line with its industry, outperforming 53.13% of the companies in the same industry.
STRS's Return On Equity of -1.82% is in line compared to the rest of the industry. STRS outperforms 51.56% of its industry peers.
Industry RankSector Rank
ROA -0.61%
ROE -1.82%
ROIC N/A
ROA(3y)5.94%
ROA(5y)4.85%
ROE(3y)12.3%
ROE(5y)10.03%
ROIC(3y)N/A
ROIC(5y)N/A
STRS Yearly ROA, ROE, ROICSTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

STRS's Profit Margin has declined in the last couple of years.
STRS's Gross Margin of 15.86% is on the low side compared to the rest of the industry. STRS is outperformed by 62.50% of its industry peers.
STRS's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for STRS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-73.92%
PM growth 5YN/A
GM growth 3Y-2.85%
GM growth 5Y0.41%
STRS Yearly Profit, Operating, Gross MarginsSTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

3

2. Health

2.1 Basic Checks

STRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
STRS has more shares outstanding than it did 1 year ago.
STRS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, STRS has a worse debt to assets ratio.
STRS Yearly Shares OutstandingSTRS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
STRS Yearly Total Debt VS Total AssetsSTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

STRS has an Altman-Z score of 0.90. This is a bad value and indicates that STRS is not financially healthy and even has some risk of bankruptcy.
STRS has a worse Altman-Z score (0.90) than 60.94% of its industry peers.
A Debt/Equity ratio of 1.04 is on the high side and indicates that STRS has dependencies on debt financing.
With a Debt to Equity ratio value of 1.04, STRS is not doing good in the industry: 64.06% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF N/A
Altman-Z 0.9
ROIC/WACCN/A
WACC7.79%
STRS Yearly LT Debt VS Equity VS FCFSTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

STRS has a Current Ratio of 10.37. This indicates that STRS is financially healthy and has no problem in meeting its short term obligations.
STRS has a Current ratio of 10.37. This is amongst the best in the industry. STRS outperforms 92.19% of its industry peers.
STRS has a Quick Ratio of 1.90. This is a normal value and indicates that STRS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.90, STRS is in the better half of the industry, outperforming 64.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.37
Quick Ratio 1.9
STRS Yearly Current Assets VS Current LiabilitesSTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

0

3. Growth

3.1 Past

STRS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -252.19%.
The earnings per share for STRS have been decreasing by -67.42% on average. This is quite bad
Looking at the last year, STRS shows a very negative growth in Revenue. The Revenue has decreased by -16.54% in the last year.
STRS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.09% yearly.
EPS 1Y (TTM)-252.19%
EPS 3Y-67.42%
EPS 5YN/A
EPS Q2Q%114.88%
Revenue 1Y (TTM)-16.54%
Revenue growth 3Y24.32%
Revenue growth 5Y-10.09%
Sales Q2Q%36.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
STRS Yearly Revenue VS EstimatesSTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for STRS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STRS Price Earnings VS Forward Price EarningsSTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STRS Per share dataSTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

STRS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STRATUS PROPERTIES INC

NASDAQ:STRS (10/21/2025, 8:00:00 PM)

19.3

-0.34 (-1.73%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-18 2025-08-18
Earnings (Next)11-11 2025-11-11
Inst Owners51.47%
Inst Owner Change-0.01%
Ins Owners10.78%
Ins Owner Change1.48%
Market Cap155.94M
Analysts0
Price TargetN/A
Short Float %1.18%
Short Ratio8.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)N/A
DP-7.34%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.35
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 0.81
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-4.88
FCFYN/A
OCF(TTM)-2.39
OCFYN/A
SpS4.43
BVpS23.75
TBVpS23.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.61%
ROE -1.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.86%
FCFM N/A
ROA(3y)5.94%
ROA(5y)4.85%
ROE(3y)12.3%
ROE(5y)10.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-73.92%
PM growth 5YN/A
GM growth 3Y-2.85%
GM growth 5Y0.41%
F-Score1
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 364.47%
Cap/Sales 56.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.37
Quick Ratio 1.9
Altman-Z 0.9
F-Score1
WACC7.79%
ROIC/WACCN/A
Cap/Depr(3y)1041.88%
Cap/Depr(5y)673.38%
Cap/Sales(3y)155.35%
Cap/Sales(5y)109.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-252.19%
EPS 3Y-67.42%
EPS 5YN/A
EPS Q2Q%114.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.54%
Revenue growth 3Y24.32%
Revenue growth 5Y-10.09%
Sales Q2Q%36.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-169.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y55.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.86%
OCF growth 3YN/A
OCF growth 5YN/A